Max Healthcare Institute (MAXHEALTH) — Financial Results

Max Healthcare reported Q3 FY'26 revenue of ₹2,608 crores, growing 10% YoY, with operating EBITDA at ₹648 crores (up 4% YoY). Nine-month revenue reached ₹7,874 crores (19% YoY growth). The company achieved 21 consecutive quarters of YoY growth despite temporary insurance disruptions and CGHS pricing changes. Capacity expansion progresses with 200 beds at Max Smart, 450-bed Pune hospital planned by 2030, and operational bed target reaching 6,000 by FY'27 from current 4,800. CGHS rate revisions provide ₹140 crores net sustained positive impact, offset partially by GST effects.

📄 View Original Announcement (PDF)

📊 Stock Analysis — MAXHEALTH ✨ Ask AI About This

About Max Healthcare Institute Limited (MAXHEALTH)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,02,200.33 Cr P/E: 101.2

View full MAXHEALTH stock details →

📡 Get AI alerts when MAXHEALTH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MAXHEALTH — Free

💡 Ask AI about this filing

"How does this financial results affect Max Healthcare Institute Limited's outlook?" "What did Max Healthcare Institute Limited announce on 12 February 2026?" "Is this positive or negative for MAXHEALTH?"

Ask AI Free →

📊 More MAXHEALTH filings

See all MAXHEALTH filings →

🔥 Also filed on 12 February 2026

COALINDIA Coal India Limited Corporate Action COALINDIA Coal India Limited Corporate Action BAJFINANCE Bajaj Finance Limited Corporate Action TATASTEEL Tata Steel Limited Financial Results APOLLOHOSP Apollo Hospitals Enterprise Limited Financial Results DIVISLAB Divi's Laboratories Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MAXHEALTH files new disclosures

Track MAXHEALTH filings, board meetings, and corporate actions. Free email alerts at 5 PM.